[4] Reiner Ž, et al. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries--Findings from the EUROASPIRE IV survey[J]. Atherosclerosis, 2016, 246: 243-50. [5] Leucker T...
These guidelines discuss the role of atropine, benzodiazepines, calcium, digoxin-specif i c immune antibody fragments, electrical pacing, fl umazenil, glucagon, hemodialysis, hydroxocobalamin, hyperbaric oxygen, insulin, intravenous lipid emulsion, lidocaine, methylene blue, naloxone, pralidoxime, sodium ...
An agent with lipid-lowering, antihypertensive, positive inotropic, negative chronotropic, vasodilating, diuretic, anorexigenic, weight-reducing, cathartic, hypoglycemic, tranquilizing, hypnotic and antidepressive qualities. Am J Cardiol. 1984;53:261–262. doi: 10.1016/0002-9149(84)90725-2 63. Fleg ...
烟酸+拉罗皮兰对血脂的作用“Basedonpreviousobservationalstudiesandrandomizedtrials,itwasanticipatedsuchlipiddifferencesmighttranslateintoa10-15%reductioninvascularevents〞EURHeartJournal2022随访时间LDL-C(mg/dL)HDL-C(mg/dL)TG(mg/dL)1-126-354-76-31平均水平-106-33(mmol/L)(-0.25)(0.16)-0.37在25,673例...
0 0 0 0 0 0 PDF下载 引用本文 PERMISSIONS Request permissions for this article from CCC. © REQUEST PERMISSIONS 评价本文 确定 放弃 *以上评分为匿名评价 试读结束,您可以通过登录机构账户或个人账户后获取全文阅读权限。 已是订阅账户? 登录
of guidelines for CVD prevention in women published by the American Heart Association; Details of a historical prospective cohort analysis conducted among high-risk women; Assessment of the attainment of optimal lipid levels and the use of antihyperlipidaemic treatment as outlined in the guidelines.do...
Impact of new lipid management guidelines on the treatment of extreme and very high‐risk patients: AACE/ACE and AHA/ACC guidelinesImpact of new lipid management guidelines on the treatment of extreme and very high‐risk patients: AACE/ACE and AHA/ACC guidelinesdoi:10.1111/1753-0407.12998Paul...
“The TRANSFORM trial brings together the power of AI for staging coronary disease and the well-documented benefits of advanced lipid lowering, anti-thrombotic, anti-inflammatory and cardiometabolic medications to create an individual care plan for patients at risk for cardiovascular events,...
women regardless of race and ethnicity; however, these guidelines are not equally incorporated into clinical practice. This scientific statement reviews the current evidence on racial and ethnic differences in cardiovascular risk factors and current ...
摘要: Despite decades of treating individuals to a low-density lipoprotein cholesterol (LDL-C) goal,the new A lipid profile, liver function tests, A1C, and thyroid function tests should be obtained atbaseline LDL-C lowering is achieved, but that is not the reason to check FLPs regularly. 展...